Halozyme Therapeutics Inc $9.80

down -0.08


19/9/2014 04:00 PM  |  NASDAQ : HALO  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get HALO Trend Analysis - it has underperformed the S&P 500 by 20%

Partner Headlines

  1. Insider Buys at Halozyme Look to Improve Stock Outlook

    GuruFocus
  2. Halozyme Announces SWOG Will Resume Clinical Trial of PEGPH20 In Combo ...

    Benzinga
  3. Morning Market Movers

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. How Can Mattel, Inc. And Other Toymakers Beat Lego?

    Benzinga
  6. Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast ...

    Benzinga
  7. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  8. Halozyme Therapeutics Receives Favorable FDA Decision

    Benzinga
  9. Halozyme Announces Resumption of Patient Enrollment, Dosing in PEGPH20 ...

    Benzinga
  10. Benzinga's Top Initiations

    Benzinga
  11. JP Morgan Initiates Halozyme Therapeutics With Outperform

    Benzinga
  12. Benzinga's Top #PreMarket Gainers

    Benzinga
  13. Mid-Day Market Update: US Stocks Surge; PVH Shares Slip On Downbeat Results

    Benzinga
  14. Shares Of Halozyme Up 14% Following FDA Removal Of Hold On PEGPH20

    Benzinga
  15. Morning Market Movers

    Benzinga
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth ...

    Benzinga
  18. Mid-Day Movers: GORO, HALO, COCO, UEC, EVDY Moving Higher; RDEN, CALL, ...

    Benzinga
  19. Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises ...

    Benzinga
  20. Mid-Morning Market Update: Markets Gain; Elizabeth Arden To Explore Strategic ...

    Benzinga
  21. Morning Market Movers

    Benzinga
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats ...

    Benzinga
  24. Morning Market Movers

    Benzinga
  25. Benzinga's Top #PreMarket Gainers

    Benzinga
  26. Benzinga's Top Initiations

    Benzinga
  27. Markets Falling? Get Your Defense Ready

    Benzinga
  28. Morning Market Losers

    Benzinga
  29. Benzinga's Top #PreMarket Losers

    Benzinga
  30. UPDATE: Halozyme Reports Clinical Hold of PEGPH20 Pancreatic Cancer Trial ...

    Benzinga
  31. Biotechs Struggling To Find A Bottom

    Benzinga
  32. Halozyme Announces Preclinical Data Presentations At The Association Of ...

    Benzinga
  33. Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum ...

    Benzinga
  34. Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat ...

    Benzinga
  35. Halozyme Shares Plummet as Concerns Halt Trial

    FoxBusiness
  36. Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates

    Benzinga
  37. Benzinga's Top #PreMarket Losers

    Benzinga
  38. UPDATE: Halozyme Announces Temporary Halt of Phase 2 Trial Enrollment

    Benzinga
  39. Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 ...

    Benzinga
  40. Morning Market Movers

    Benzinga
  41. Mid-Afternoon Market Update: Markets Take a Sharp Dip to the Downside, ...

    Benzinga
  42. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving ...

    Benzinga
  43. UPDATE: Halozyme Spikes Higher on Positive CNBC Comments

    Benzinga
  44. Microsoft's First Xbox TV Series Slated For 1H 2014

    Benzinga
  45. Hottest Game Systems For Christmas: PlayStation 4 vs. Xbox One vs. Wii ...

    Benzinga
  46. Halozyme Receives Milestone Payment of $10M from Roche Following Commercial ...

    Benzinga
  47. Coming Soon: Microsoft Cortana vs. Apple Siri (AAPL, MSFT)

    Benzinga
  48. Halozyme Announces Roche Receives Marketing Authorization for Herceptin ...

    Benzinga
  49. Benzinga Market Wrap for Thursday, August 1: Record Highs!

    Benzinga
  50. Mid-Afternoon Market Update: Trulia Rises as Hanger Drops on its Second-Quarter ...

    Benzinga
Trading Center